Mutation analysis in the family of a child with 21-hydroxylase deficiency showed that the father and affected child were homozygous for a mutation, A/C655G, believed to activate a cryptic splice site in intron 2 of the 21-hydroxylase gene. The father, who was clinically asymptomatic, showed no biochemical evidence of disease. These results create problems for the management of future pregnancies in such families and for the interpretation of the risk associated with carrier status for this mutation. (JMed Genet 1996;33:798-799) Key words: 21-hydroxylase; mutation; non-expression. The index case is a girl of Arab extraction and the product of a consanguineous marriage. She was born at 36 weeks' gestation following a normal pregnancy and delivery and was noted to have ambiguous genitalia (large phallus, fused labioscrotal folds, and 46,XX karyotype). Investigations in the United Arab Emirates confirmed the diagnosis of 2 1-hydroxylase deficiency (details not available). The parents were advised to rear the baby as a girl. She was started on steroid replacement therapy with plans for reconstructive surgery at a later date. However, the parents did not accept the diagnosis and decided to rear the child as a boy. The child was referred to our centre for a second opinion at the age of 13 months. She was well controlled on hydrocortisone 5 mg twice daily (22 mg/m2/day) and fluodrocortisone 75 jg once daily (167 jig/m2/day). Examination of her genitalia showed a large clitoris, an empty scrotum, and a urogenital sinus. The diagnosis of CYP2 1 deficiency was confirmed on urinary steroid profile (high excretion rates of 17-hydroxyprogesterone metabolites). Pelvic ultrasound scan showed a normal prepubertal uterus. Sinography showed a blind ended pouch 3 cm long from the base of the phallus. Blood for DNA studies was collected from the child and her parents. Cliteroplasty and vaginal reconstruction were performed at our centre.
Deficiency of the steroid 2 1-hydroxylase (CYP2 1) enzyme is the most frequent cause of congenital adrenal hyperplasia (CAH). It is characterised by glucocorticoid and mineralocorticoid insufficiency leading to salt loss in the neonatal period, and increased synthesis of adrenal androgens leading to virilisation of the female fetus in utero and to precocious puberty in undiagnosed males.
The gene, CYP2 1, is located on chromosome 6p within the HLA class III region. More The index case is a girl of Arab extraction and the product of a consanguineous marriage. She was born at 36 weeks' gestation following a normal pregnancy and delivery and was noted to have ambiguous genitalia (large phallus, fused labioscrotal folds, and 46,XX karyotype). Investigations in the United Arab Emirates confirmed the diagnosis of 2 1-hydroxylase deficiency (details not available). The parents were advised to rear the baby as a girl. She was started on steroid replacement therapy with plans for reconstructive surgery at a later date. However, the parents did not accept the diagnosis and decided to rear the child as a boy. The child was referred to our centre for a second opinion at the age of 13 months. She was well controlled on hydrocortisone 5 mg twice daily (22 mg/m2/day) and fluodrocortisone 75 jg once daily (167 jig/m2/day). Examination of her genitalia showed a large clitoris, an empty scrotum, and a urogenital sinus. The diagnosis of CYP2 1 deficiency was confirmed on urinary steroid profile (high excretion rates of 17-hydroxyprogesterone metabolites). Pelvic ultrasound scan showed a normal prepubertal uterus. Sinography showed a blind ended pouch 3 cm long from the base of the phallus. Blood for DNA studies was collected from the child and her parents. Cliteroplasty and vaginal reconstruction were performed at our centre.
The parents were heterozygous for polymorphisms in C46 and TNFa,7 with one allele in common. The index case had inherited identical linked markers from each parent.
The A/C655G mutation in CYP21 was sought by amplification of genomic DNA in a 25 ,ul reaction mix containing 1.5 mmol/l MgCl2, 1 gmol/l each primer (nts 707-7258 and 369-388), 200 gmol/l each dNTP, 50 mmol/l KC1, 10 mmol/l Tris, pH 9.0, 0.1% Triton X-100, and 0.25 units of Taq polymerase. Following an initial denaturation step, 35 cycles of 0.5 minutes at 62°C, 0.5 minutes at 72°C, and 0.5 minutes at 94°C were carried out. The PCR product was digested with MwoI to detect the presence of the A/C655G mutation and the T453C polymorphism.
Mutation analysis showed that the index case was homozygous for the splice mutation in intron 2 and the mother heterozygous for this mutation. The father, however, was found to be homozygous for the same mutation. Nonamplification of one paternal allele was excluded by amplification with an additional primer pair (nts 600-618 and 797-816) followed by digestion of the product with MwoI.
Samples from subjects lacking either CYP21 or CYP2 1 P were used as controls. 9 Mutation analysis is the most accurate form of genetic diagnosis as it detects the actual sequence change causing the disease and is therefore less susceptible to error through recombination. However, here we describe a family in whom one of the parents is homozygous for a known deleterious mutation but clinically asymptomatic and biochemically normal except for a slightly raised urinary pregnanetriol and mildly raised PRA. Such a situation has been recently described'0 but no satisfactory explanation was presented.
The association of the A/C655G mutation with activation of a cryptic splice site has been described in vitro4 11 and in vivo (C Avey, G Rumsby, G Conway, manuscript in preparation). Mutations which affect splicing are known to be leaky,'2 the cell making a certain amount of normally spliced mRNA, and one could therefore hypothesise that the mutation is variably expressed. Such an explanation may help in part to account for the inexact relation between genotype and phenotype in CYP21 deficiency. 13 As no additional homozygotes were available for study in this particular family, it is not possible to know whether such variation can occur within a family. A second possibility is that the A/C655G mutation may occur in the presence of an additional sequence change in either the intron or neighbouring exon, which negates the influence of the mutation on the cryptic splice site. The sequence data obtained in the present study did not, however, identify any additional pathological sequence changes in this region. This subject was, however, homozygous for five polymorphisms in the intron 2/exon 3 region and it was therefore not possible to claim with certainty that both alleles were sequenced. Lastly, 655G may simply be in association with another mutation, although this proposal is unlikely in view of the expression studies discussed above.
Family studies on patients with CYP2 1 deficiency have identified subjects who had not presented clinically although were found to have the disease on biochemical testing (cryptic CAH). Genetic 
